Personalized prostate cancer screening for diverse men
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population
This research aims to find better ways to screen for prostate cancer, especially for Black men, by using personalized approaches based on individual risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11158677 on NIH RePORTER |
What this research studies
Current prostate cancer screening with PSA tests can sometimes lead to unnecessary treatments, even though it helps save lives. This project explores a new screening method that uses your initial PSA level to decide how often you need future screenings, making it more personalized. The goal is to reduce over-treatment while still catching aggressive cancers early. We also want to make sure this new approach works well for all men, including those from diverse backgrounds who are often underrepresented in health studies.
Who could benefit from this research
Good fit: Ideal candidates for this type of research would be men at risk for prostate cancer, particularly Black men, who are considering or undergoing prostate cancer screening.
Not a fit: Patients who have already been diagnosed with prostate cancer or are not candidates for screening would not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to more effective and less burdensome prostate cancer screening guidelines, potentially reducing unnecessary treatments while maintaining early detection for aggressive cancers.
How similar studies have performed: While PSA-based risk-stratified screening is supported by some agencies, more validation and longer-term follow-up are needed, especially for diverse populations.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Langston, Marvin Epolian — Stanford University
- Study coordinator: Langston, Marvin Epolian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.